MNC Capital Inc. represented Anton Hopf Kunststoffverarbeitung GmbH (“Anton Hopf”) in the sale to Promepla SAM (“Promepla”). Anton Hopf engaged MNC to identify the right strategic partner to support the company in their continued growth and development. Located in Cadolzburg, Germany, Anton Hopf is a leading vertically integrated injection molder, providing high quality precision components for both medical and industrial applications. Anton Hopf’s products include stopcocks, ENfit components, roller clamps, and caps. The company holds many patents and provides customized R&D solutions for its clients.
Promepla is an innovative Monaco-based contract manufacturer of finished and semi-finished single- use medical devices and components. Their focus is on fluid management, as well as other medical and life science products. Promepla’s acquisition of Anton Hopf provides them with additional manufacturing capabilities, and an improved product offering.
MNC Capital Inc.
MNC Capital is a leading investment bank focusing on mergers and acquisitions, with over 40 years of experience in representing both buyers and sellers. We differentiate ourselves through our proactive individual approach, deep industry expertise, and ability to create unique strategic solutions. We work by industry, not by geography. With clients throughout the world, MNC continues to be a leading investment bank in the healthcare industry.
